Back
Oramed Pharmaceuticals Stock Price Chart
7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Sell
24
ORMP
Oramed Pharmaceuticals
Last Price:
$2.13
Seasonality Move:
-1.36%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORMP is experiencing slight buying pressure.
Oramed Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.14 | Sell |
| 20-day SMA: | 2.16 | Sell |
| 50-day SMA: | 2.2 | Sell |
| 200-day SMA: | 2.29 | Sell |
| 8-day EMA: | 1.35 | Buy |
| 20-day EMA: | 0.7 | Buy |
| 50-day EMA: | 0.31 | Buy |
| 200-day EMA: | 0.08 | Buy |
Oramed Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.47 | Buy |
| Relative Strength Index (14 RSI): | 47.21 | Sell |
| Chaikin Money Flow: | 4109 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.13 - 2.21) | Sell |
| Bollinger Bands (100): | (2.12 - 2.34) | Sell |
Oramed Pharmaceuticals Technical Analysis
| Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Oramed Pharmaceuticals Stock
Is Oramed Pharmaceuticals Stock a Buy?
-
Oramed Pharmaceuticals share price is 2.14 while ORMP 8-day simple moving average is 2.14, which is a Sell signal.
-
The stock price of ORMP is 2.14 while Oramed Pharmaceuticals 20-day SMA is 2.16, which makes it a Sell.
-
Oramed Pharmaceuticals 50-day simple moving average is 2.20 while ORMP share price is 2.14, making it a Sell technically.
-
ORMP stock price is 2.14 and Oramed Pharmaceuticals 200-day simple moving average is 2.29, creating a Sell signal.
ORMP Technical Analysis vs Fundamental Analysis
Sell
24
Oramed Pharmaceuticals (ORMP)
is a Sell
Is Oramed Pharmaceuticals a Buy or a Sell?
-
Oramed Pharmaceuticals stock is rated a SellThe current Oramed Pharmaceuticals [ORMP] share price is $2.14. The Score for ORMP is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
Oramed Pharmaceuticals Stock Info
Market Cap:
87.2M
Price in USD:
2.14
Share Volume:
18.7K
Oramed Pharmaceuticals 52-Week Range
52-Week High:
3.09
52-Week Low:
1.82
Sell
24
Oramed Pharmaceuticals (ORMP)
is a Sell
Oramed Pharmaceuticals Share Price Forecast
-
What is the Oramed Pharmaceuticals stock price today?The Oramed Pharmaceuticals stock price is 2.14 USD today.
-
Will ORMP stock go up or go down?Oramed Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Oramed Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Oramed Pharmaceuticals is overvalued.
Is Oramed Pharmaceuticals Stock a Buy?
-
Oramed Pharmaceuticals share price is 2.14 while ORMP 8-day exponential moving average is 1.35, which is a Buy signal.
-
The stock price of ORMP is 2.14 while Oramed Pharmaceuticals 20-day EMA is 0.70, which makes it a Buy.
-
Oramed Pharmaceuticals 50-day exponential moving average is 0.31 while ORMP share price is 2.14, making it a Buy technically.
-
ORMP stock price is 2.14 and Oramed Pharmaceuticals 200-day simple moving average is 0.08, creating a Buy signal.
Fundamental Analysis of Oramed Pharmaceuticals
Is Oramed Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.43 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Oramed Pharmaceuticals
Should I short Oramed Pharmaceuticals stock?
-
ORMP Moving Average Covergence Divergence (MACD) indicator is 0.47, suggesting Oramed Pharmaceuticals is a Buy
-
Oramed Pharmaceuticals Relative Strength Index (RSI) is 47.21, which suggest Oramed Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Oramed Pharmaceuticals is (2.13 - 2.21), which suggest Oramed Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Oramed Pharmaceuticals is (2.12 - 2.34), which suggest Oramed Pharmaceuticals is a Sell
* Oramed Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.